ReviewProceedings of the Japan Academy. Series B, Physical and biological sciences2024

Chondroitin sulfate proteoglycan 4: An attractive target for antibody-based immunotherapy.

Tomohiro Kurokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.